Exploring the transcriptome of hormone-naive multifocal prostate cancer and matched lymph node metastases-Reference-Cited by-同舟云学术

Exploring the transcriptome of hormone-naive multifocal prostate cancer and matched lymph node metastases

Published:2018-11-19 Issue:12 Volume:119 Page:1527-1537
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Schmidt Linnéa,Møller Mia,Haldrup Christa,Strand Siri H.,Vang Søren,Hedegaard Jakob,Høyer Søren,Borre Michael,Ørntoft Torben,Sørensen Karina Dalsgaard

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/s41416-018-0321-5.pdf

Reference62 articles.

1. Thompson, I. et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J. Urol. 177, 2106–2131 (2007).

2. Boutros, P. C. et al. Spatial genomic heterogeneity within localized, multifocal prostate cancer. Nat. Genet. 47, 736–745 (2015).

3. Lindberg, J. et al. Exome sequencing of prostate cancer supports the hypothesis of independent tumour origins. Eur. Urol. 63, 347–353 (2013).

4. Mehra, R. et al. Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer. Cancer Res. 68, 3584–3590 (2008).

5. Liu, W. et al. Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat. Med. 15, 559–565 (2009).

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metastatic hormone-naïve prostate cancer: a distinct biological entity;Trends in Cancer;2024-09

2. Gene Signature for Predicting Metastasis in Prostate Cancer Using Primary Tumor Expression Profiles;2024-08-31

3. Prostate cancer: Molecular aspects, consequences, and opportunities of the multifocal nature;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-03

4. Stroma-specific gene expression signature identifies prostate cancer subtype with high recurrence risk;npj Precision Oncology;2024-02-23

5. Systematic review and integrated analysis of prognostic gene signatures for prostate cancer patients;Discover Oncology;2023-12-19